11.3. Investigator Signatory Obligations
Each clinical study report will be signed by the coordinating investigator.  The coordinating investigator will be identified by Kite Pharma under the following criteria:  A recognized expert in the disease setting  Provided significant contributions to the design or analysis of study data  Participate in the study and enrolled a high number of eligible subjects